Sbi Life

HDFC Life's non-par share declined sharply to 18 percent in H1FY26 from 32 percent a year ago, a deviation in an otherwise uniform industry tilt toward guaranteed-return products.

Buy SBI Life; target of Rs 2100: Emkay Global Financial

Emkay Global Financial is bullish on SBI Life has recommended buy rating on the stock with a target price of Rs 2100 in its research report dated October 25, 2025.

SBI Life shares gain 2% on solid Q1 earnings show; should you buy, sell, or hold?

SBI Life continued to report improvement in the VNB performance in 1QFY26, aided by a shift in the product mix toward traditional products.

SBI Life Q1 Preview: Modest APE growth seen, margin gains to drive VNB

SBI Life is expected to report modest growth in APE and healthy expansion in VNB margins for the June quarter, aided by a favourable product mix, even as ULIP sales moderate and investments in distribution weigh on profits

Buy SBI Life; target of Rs 1950: Emkay Global Financial

Emkay Global Financial is bullish on SBI Life has recommended buy rating on the stock with a target price of Rs 1950 in its research report dated April 25, 2025.

SBI Life eyes stable margins in FY26 as it shifts focus to traditional products from market-linked plans

SBI Life expects margins to remain steady in the range of 27–28 percent, as it shifts more focus towards traditional insurance products

SBI Life eyes 13-14% growth in individual premiums for FY26, outpacing industry estimates

SBI Life saw a modest 0.3 percent year-on-year (YoY) increase in net profit, reaching Rs 813 crore in Q4

SBI Life eyes 13-14% growth in individual premiums for FY26, outpacing industry estimates

SBI Life saw a modest 0.3 percent year-on-year (YoY) increase in net profit, reaching Rs 813 crore in Q4

SBI Life Q4 Preview: Muted show likely amid modest APE, flat VNB growth

SBI Life is expected to post a 4.2 percent year-on-year (YoY) growth in APE in Q4FY25

Insurance companies see no benefit from open architecture; Leaders cite unemployment, mis-selling concerns

Moreover, companies have not seen much success with the open architecture model

Centre's ULIP tax clarification may push insurers, policyholders towards new products

While ULIP sales have significantly driven premium growth for private insurers, a downturn in market stability typically leads to reduced demand for ULIPs, with effects usually seen nine to twelve months later

HDFC Life, SBI Life, other insurance stocks tumble after Budget 2025 incentivises new income tax regime

Insurance stocks selloff: The new tax regime provides no deductions for health and life insurances

Buy SBI Life; target of Rs 1850: Emkay Global Financial

Emkay Global Financial is bullish on SBI Life has recommended buy rating on the stock with a target price of Rs 1850 in its research report dated January 19, 2025.

SBI Life Q3: Brokerages maintain bullishness, optimistic on growth prospects

Given favorable valuations and improved growth visibility, brokerages upgraded their ratings on SBI Life, while also hiking their target prices on the stock.

SBI Life Q3 net profit surges 71% YoY to Rs 551 crore, beats estimates; premium income rises 11%

SBI Life’s net premium income also saw a strong growth. The insurer reported a net premium income of Rs 24,828 crore, up 11% percent from the Rs 22,326 lakh crore reported in Q3 of FY 24.

SBI Life Q3 FY25 results preview: APE seen up 6.5%, VNB margin likely to contract

SBI Life Q3 Results Preview: SBI Life’s Q3 FY25 APE is expected to grow 6.5 percent, but VNB margin may contract 90 basis points due to regulatory changes and higher ULIPs in the product mix.

SBI Life, HDFC Life stocks fall as FM Sitharaman advises banks to deter from selling insurance and focus on core banking

Insurers get a large part of their business from banks' distribution and hence, Sitharaman's statement created uncertainty on that business

Buy SBI Life; target of Rs 1900: Emkay

Emkay is bullish on SBI Life has recommended buy rating on the stock with a target price of Rs 1900 in its research report dated July 24, 2024.

SBI Life Insurance Q1 net profit rises 36% on-year to Rs 519 crore

The solvency ratio dipped to 2.01 percent versus 2.15 percent last year.

Buy SBI Life; target of Rs 1800: Emkay Global Financial

Emkay Global Financial is bullish on SBI Life has recommended buy rating on the stock with a target price of Rs 1800 in its research report dated April 27, 2024.

SBI Life Insurance Q4 results: Net profit rises 4 % to Rs 810 crore

SBI Life Q4: The solvency ratio of the insurer stood at 1.96 percent

Insurance stocks gain on IRDAI's surrender value rollback; brokerages turn positive

Status quo on surrender values by the insurance regulator is a big relief for life insurers, says brokerages, which expect these firms to maintain profitability

Insurance stocks gain amid reports of IRDAI plan to revisit surrender charges

According to reports, IRDAI is likely to consider rationalisation of proposed surrender value in its March board meeting

Buy SBI Life; target of Rs 1750: Emkay Global Financial

Emkay Global Financial is bullish on SBI Life has recommended buy rating on the stock with a target price of Rs 1750 in its research report dated January 26, 2024.

Dec 23 "highly significant" for meeting FY24 growth target for life-insurance industry: Emkay Global

They expect retail annual premium equivalent (APE) to grow at 6-7 percent year-on-year (YoY) in FY24, led by private sector growth of 11-12 percent